BioSpace News Archive

Protara Therapeutics, Inc. announced the grants of inducement non-qualified stock options to purchase an aggregate of 5,200 shares of common stock to two new employees.

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, and Veeva Systems (NYSE: VEEV), today announced a strategic partnership to augment the build of Axsome’s Digital-Centric Commercialization (DCC™) platform.

ChromaDex Corp. (Nasdaq:CDXC) today reported third quarter financial results.

Viemed Healthcare, Inc., a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced that it has reported its financial results for the three and nine months ended September 30, 2020.

Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for treatment of oncology, metabolic, autoimmune and other major diseases, and Eli Lilly and Company (“Lilly”, NYSE: LLY) jointly announce that results of seven clinical studies of TYVYT®

Arcturus Therapeutics Holdings Inc. announced that the Company will be presenting at upcoming investor and scientific conferences virtually:

Guardian Research Network, Inc. announced Shirley Trainor-Thomas, a clinical research and healthcare industry executive, joined as Vice President, Network Partners, effective immediately.

Rafarma Pharmaceuticals, Inc. OTC: is pleased to announce that the elite Chicago auditing firm LJ Soldinger Associates has been retained to provide auditing services for the resulting Rafarma group of companies from the Biocogency/Rafarma merger.

Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, today announced that it will present initial data from its Phase 1 UNIVERSAL trial of ALLO-715, an anti-BCMA AlloCAR T therapy, in relapsed/refractory multiple myeloma in an oral presentation at the 62nd Annual Meeting of the American Society of Hematology (ASH)

Anatomage Inc, a medical technology leader in 3D imaging technology, announces the launch of a physiology section and other major updates that will be included in the Anatomage eBook.